Literature DB >> 3401702

Selective messenger RNA reduction in Alzheimer's disease.

D R McLachlan1, W J Lukiw, L Wong, C Bergeron, N T Bech-Hansen.   

Abstract

The relative abundance of 7 messenger RNAs extracted from Alzheimer and control neocortex were examined by Northern and quantitative dot blot analysis. The average yield of mRNA coding for NF-L, the 68-kDa moiety of neurofilament protein, was reduced to 27% of control when expressed as the percentage of total RNA or 14% when expressed per gram of neocortex. In contrast, the yields of 6 other messenger RNAs fell into two categories: those which were statistically significantly reduced to about 65% of control and those which were not reduced when expressed as percentage of total RNA. The anomalous low abundance of neuron specific NF-L mRNA, coding for the lowest molecular weight moiety of neurofilament proteins, in cerebral cortex of Alzheimer's disease cannot be adequately accounted for by a non-specific effect of brain damage, neuron cell loss or neurons with neurofibrillary degeneration. We speculate that this mRNA decrease is related to a functional deficit of gene expression in Alzheimer's disease, perhaps related to the non-random increase in chromatin compaction previously reported from this laboratory. The inability of neurons to maintain homeostatic amounts of NF-L transcription products may be linked to the accumulation of abnormal filamentous components characteristically associated with the diseased cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401702     DOI: 10.1016/0169-328x(88)90048-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Increased tau messenger RNA in Alzheimer's disease hippocampus.

Authors:  A J Barton; P J Harrison; A Najlerahim; J Heffernan; B McDonald; J R Robinson; D C Davies; W J Harrison; P Mitra; J A Hardy
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 2.  The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.

Authors:  W J Lukiw; H J Cho; J C Kaufmann; D R Crapper McLachlan
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

3.  Aberrant GAP-43 gene expression in Alzheimer's disease.

Authors:  S M de la Monte; S C Ng; D W Hsu
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit.

Authors:  G A Elder; V L Friedrich; A Margita; R A Lazzarini
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

Review 5.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

Review 6.  Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?

Authors:  D R McLachlan; T P Kruck; W J Lukiw; S S Krishnan
Journal:  CMAJ       Date:  1991-10-01       Impact factor: 8.262

7.  Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease.

Authors:  W S Griffin; C Ling; C L White; M Morrison-Bogorad
Journal:  Alzheimer Dis Assoc Disord       Date:  1990       Impact factor: 2.703

8.  Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod.

Authors:  Henryk Jęśko; Iga Wieczorek; Przemysław Leonard Wencel; Magdalena Gąssowska-Dobrowolska; Walter J Lukiw; Robert Piotr Strosznajder
Journal:  Front Mol Neurosci       Date:  2021-07-09       Impact factor: 5.639

9.  Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.

Authors:  Yuhai Zhao; Frederic Calon; Carl Julien; Jeremy W Winkler; Nicos A Petasis; Walter J Lukiw; Nicolas G Bazan
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

10.  Neurofilamentopathy in neurodegenerative diseases.

Authors:  Quan Liu; Fang Xie; Abdiel Alvarado-Diaz; Mark A Smith; Paula I Moreira; Xiongwei Zhu; George Perry
Journal:  Open Neurol J       Date:  2011-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.